Published in Cancer Weekly, August 19th, 1996
These potent chemotherapy drugs are standard treatment for conditions such as ovarian cancer. Debate has surrounded how to best administer these agents in order to maximize their effectiveness while minimizing their toxicity.
Recent economic pressures from insurance companies have favored the use of a shorter chemotherapy infusion time and an outpatient...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.